Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

University of Vienna

Headquarters: Vienna, Austria
Year Founded: 1365
Status: Non-biopharma

Biopharma related deals can be found by searching the organization's name in the Deals Module.

BioCentury | Apr 1, 2025
Distillery Therapeutics

Inhibiting SSAT activity for inflammatory skin diseases

BioCentury | May 10, 2023
Discovery & Translation

Integrated’s AI platform to discover senolytic compounds; plus Editas’ transgene knock-in method and more

BioCentury’s roundup of translational news
BioCentury | Oct 19, 2021
Management Tracks

Carl June joins Bioheng’s SAB

Plus: Myriad, Kura, Ideaya, IASO, OncoCyte and more
BioCentury | Aug 27, 2021
Translation in Brief

Stanford tech advances RNA structure prediction

Plus: Denali, Editas, Fred Hutchinson and more
BioCentury | Jul 23, 2021
Finance

Caribou gives back early gains after pricing $304M IPO

Gene editing company draws on recent investor interest in sector
Items per page:
1 - 10 of 91